After a year and a half of scale-backs and tempered growth, LifeStance Health (Nasdaq: LFST) is planning a return to M&A. The target for that comeback: 2026. LifeStance is still completing processes designed to improve efficiency, David Bourdon, the company’s chief financial officer, said at the 22nd Annual Morgan Stanley Healthcare Conference. Along those lines, LifeStance maintains its plans to exit 2025 with double-digit margins, he added. After two years of scaling back growth and seeking to improve efficiency, LifeStance plans to chart a more aggressive growth course.
Read the full article: LifeStance Poised for M&A Comeback after Efficiency Overhaul //
Source: https://bhbusiness.com/2024/09/04/lifestance-poised-for-ma-comeback-after-efficiency-overhaul